Prime Medicine PRME 深 沪
等待开盘 07-17 09:30:00 美东时间
3.22
-0.270
-7.74%
华盛通- 最 高3.45
- 今 开3.44
- 成交量 367.86万股
- 最 低 3.17
- 昨 收 3.49
- 总市值 5.82亿
- 52周最高 6.94
- 市盈率 静 --
- 换手率 2.04%
- 52周最低 2.67
- 委 比 -20.60%
- 总股本 1.81亿
- 历史最高 21.73
- 量 比 0.87
- 振 幅 8.02%
- 历史最低 1.11
- 每 手 1
- 风险率 0.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | AI基建供应商PENG涨逾25%！季报营收大超预期；金山云升逾11%，受益于小米算力投入激增
AI基建供应商PENG涨逾25%！季报营收大超预期；WULF涨近13%，此前与Anthropic签署20年超级租赁协议；金山云升逾11%，受益于小米算力投入激增>>
07-09 18:44
Prime Medicine resolves arbitration, clarifying PM647 development rights
The latest announcement is out from Prime Medicine, Inc. ( ($PRME) ). On July 6...
07-08 20:29
Tribunal Declares Prime Medicine's PM657 Is Within It's "Field" As Defined By Agreement With Beam Therapeutics; Company Owes No Monetary Damages To Beam
Tribunal Declares Prime Medicine's PM657 Is Within It's "Field" As Defined By Agreement With Beam Therapeutics; Company Owes No Monetary Damages To Beam
07-08 20:03
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
Prime Medicine announced a favorable resolution of its arbitration with Beam Therapeutics, confirming its rights to develop and commercialize PM647 for Alpha-1 Antitrypsin Deficiency (AATD). The tribunal ruled that Prime Medicine did not breach the 2019 Collaboration and License Agreement, and no monetary damages are owed to Beam. PM647 uses Prime Medicine’s universal liver lipid nanoparticle (LNP) to correct the E342K mutation in the SERPINA1 ge...
07-08 12:00
美股大行评级 | 康托·菲茨杰拉德大幅上调AMD、英特尔、迈威尔科技、美光、西部数据目标价！Applied、INIO、LFTO、Quantinuum获多家大行首予买入评级
今日重点评级关注：Evercore ISI集团：维持ProQR Therapeutics"跑赢大市"评级，目标价从5美元升至6美元；摩根士丹利：维持霍尼韦尔"标配"评级，目标价从245美元升至490美元
06-30 10:14
Iridium Communications, FuelCell Energy, Rocket Lab And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index gaining around 350 points on Monday. Shares of Iridium Communications Inc (NASDAQ:IRDM) rose sharply after the company announced it will be acquired by Rocket Lab. Rocket Lab and Iridium Communications announced Monday that they have entered into a d...
06-29 21:58
This Caseys Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Arthur He upgraded Prime Medicine, Inc (NASDAQ:PRME) from Neutral to ...
06-29 20:42
HC Wainwright & Co. Upgrades Prime Medicine to Buy, Announces $8 Price Target
HC Wainwright & Co. analyst Arthur He upgrades Prime Medicine (NASDAQ:PRME) from Neutral to Buy and announces $8 price target.
06-29 18:13
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.
05-27 22:51
Prime Medicine shares are trading lower after the company reported worse-than-expected Q1 sales results.
Prime Medicine shares are trading lower after the company reported worse-than-e...
05-08 00:58
